Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
Abstract To examine the effects of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, on pancreatic beta cell mass in db/db mice of different ages. db/db mice aged 6, 10, 14 and 24 weeks old were fed either standard chow (control group) or standard chow containing 0.01% luseogliflozin (luse...
Guardado en:
Autores principales: | Kiyohiko Takahashi, Akinobu Nakamura, Hideaki Miyoshi, Hiroshi Nomoto, Naoyuki Kitao, Kazuno Omori, Kohei Yamamoto, Kyu Yong Cho, Yasuo Terauchi, Tatsuya Atsumi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bbee92b9ae34d619084d38dd521929f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
por: Yoshiro Fushimi, et al.
Publicado: (2021) -
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
por: Fu W, et al.
Publicado: (2020) -
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
por: Lv J, et al.
Publicado: (2020) -
Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
por: Longxue Cai, et al.
Publicado: (2021) -
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
por: Zeng H, et al.
Publicado: (2021)